missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ OCC1 Polyclonal Antibody
Description
Despite the predicted molecular weight, OCC-1 from cell lines often migrates at ~28kDa in SDS-PAGE. A suggested positive control is 293 cell lysate. PA5-20673 can be used with blocking peptide PEP-0791.
OCC-1 (Overexpressed in colon carcinoma-1) was initially identified as a novel human cDNA overexpressed in a colon carcinoma cell line. Elevated levels of OCC-1 mRNA were observed in three of eight colon carcinomas, suggesting that OCC-1 may be a hallmark of only a subset of colon carcinomas. It is highly expressed in skeletal muscle, kidney, placenta, and pancreas tissues, with low to no expression in heart, brain, lung and liver tissues. At least two different OCC-1 mRNA species are known to exist.
Specifications
Specifications
| Antigen | OCC1 |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | C12orf75 |
| Gene Accession No. | Q8TAD7 |
| Gene Alias | adipogenesis down-regulated 3; AGD3; C12orf75; chromosome 12 open reading frame 75; OCC1; OCC-1; Overexpressed in colon carcinoma 1 protein; overexpressed in colon carcinoma-1; putative overexpressed in colon carcinoma-1 protein variant C |
| Gene Symbols | C12orf75, OCC1 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?